Clinical Trials
4 trialsNCT07108959 2025-08-07
ESPB
Alexandria University
Phase NA Not yet recruiting
NCT06207734 2025-05-01
Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Recruiting
NCT04933266 2025-04-11
Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery
Chinese University of Hong Kong
Phase NA Recruiting
NCT00095706 2015-09-25
Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
Translational Oncology Research International
Phase 1/2 Completed